Get started
Author

Amalia Tejeda Velarde

Observed names: AMALIA TEJEDA VELARDE, Amalia Tejada Velarde, Amalia Tejeda-Velarde, Amalia Tejeda‐Velarde, Amalia Velarde, amalia Tejeda-Velarde
Observed institutions: Brigham and Women's Hospital, Harvard University, Universidad de Salamanca, Instituto de Salud Carlos III, Spanish Multiple Sclerosis Network, Complejo Hospitalario de Salamanca, Centro de Investigación Biomédica en Red, Instituto Ramón y Cajal de Investigación Sanitaria, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer, Centro de Investigación Biomédica en Red de Cáncer, Hospital Universitario Ramón y Cajal
ORCID: 0000-0002-7061-8725
Observed ORCID: 0000-0002-7061-8725
OpenAlex ID: A5071731646
Barcoded viral tracing of single-cell interactions in central nervous system inflammation
2021 · Iain C. Clark, Cristina Gutiérrez-Vázquez, et al. · Science · 284
PDF
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
2020 · Sunny Malhotra, Carme Costa, et al. · Brain · 139
PDF
Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients
2020 · Ignacio Iturrieta-Zuazo, Claudia Geraldine Rita, et al. · Clinical Immunology · 105
Factors associated with dimethyl fumarate-induced lymphopenia
2019 · Susana Sainz de la Maza, Silvia Medina, et al. · Journal of the Neurological Sciences · 29
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis
2021 · Carmen Picón, Amalia Tejeda-Velarde, et al. · Frontiers in Immunology · 28
PDF
Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients
2019 · Silvia Medina, Susana Sainz de la Maza, et al. · Annals of Clinical and Translational Neurology · 25
PDF
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
2020 · Inmaculada Toboso, Amalia Tejeda-Velarde, et al. · Frontiers in Neurology · 17
PDF
Serological short-chain fatty acid and trimethylamine N-oxide microbial metabolite imbalances in young adults with acute myocardial infarction
2023 · José Avendaño-Ortiz, Álvaro Lorente-Ros, et al. · Heliyon · 16
Short‐chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study
2021 · Juan Pablo Cuello, María Luisa Martínez Ginés, et al. · European Journal of Neurology · 13
Next‐generation sequencing identifies four novel HLA class I alleles with nucleotide substitutions in the 3′ UTR
2024 · Jairo Eduardo Niño Ramírez, Francisco Javier Gil‐Etayo, et al. · HLA · 11
PDF
Cytokine profile during pregnancy predicts relapses during pregnancy and postpartum in multiple sclerosis
2020 · Juan Pablo Cuello, María Luisa Martínez Ginés, et al. · Journal of the Neurological Sciences · 9
Identification and characterization of the novel HLA‐B*49:78 allele by next‐generation sequencing
2022 · Jairo Eduardo Niño Ramírez, Antonio Balas, et al. · HLA · 7
Identification of the novel HLA‐DQA1*02:01:09:01 allele by two different next‐generation sequencing platforms
2022 · Francisco Javier Gil‐Etayo, Alberto Torío, et al. · HLA · 6
Characterization of the first HLA‐DQA1 allele with Aspartic Acid in the transmembrane domain, HLA‐DQA1*05:71
2023 · Francisco Javier Gil‐Etayo, Jairo Eduardo Niño Ramírez, et al. · HLA · 5
Detection and characterization of the novel HLA-DPA1*02:66:02N allele, with a premature stop codon in exon 2
2023 · Jairo Eduardo Niño Ramírez, Antonio Balas, et al. · Human Immunology · 5
Identification of two novel HLA‐DQB1*03:01:01 intronic variants: HLA‐DQB1*03:01:01:47 and ‐DQB1*03:01:01:48
2022 · Francisco Javier Gil Etayo, Jairo Eduardo Niño Ramírez, et al. · HLA · 5
The novel HLA‐DQB1 *03:493 allele, the first with glutamic acid at position—10 in the leader peptide
2022 · Jairo Eduardo Niño Ramírez, Francisco Javier Gil Etayo, et al. · HLA · 5
Transitions in intronic regions result in two novel HLA‐DQB1 alleles: – DQB1 *05:02:01:13 and ‐ DQB1 *05:02:01:14
2023 · Jairo Eduardo Niño Ramírez, Francisco Javier Gil‐Etayo, et al. · HLA · 4
PDF
Identification of the novel HLA‐DQA1*01:04:07 allele with a synonymous substitution and an intronic insertion
2022 · Francisco Javier Gil Etayo, Jairo Eduardo Niño Ramírez, et al. · HLA · 4
Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes
2020 · Elia Gil‐Varea, Nino Spataro, et al. · Human Mutation · 4
HLA‐DRB5*01:133, the First HLA ‐ DRB5 Allele With Arginine at Position 16 in the Peptide‐Binding Domain
2025 · Amalia Tejeda Velarde, Juan López‐Pérez, et al. · HLA · 3
A Missense Substitution in Exon 2 Generates the First HLA ‐ DQB1 *04 Allele With Glutamine at Residue 52, DQB1 *04:108
2025 · Juan López‐Pérez, Francisco Javier Gil‐Etayo, et al. · HLA · 3
Detection of the novel HLA‐DQA1*05:73 allele with an amino acid substitution in the α2 extracellular domain
2024 · Francisco Javier Gil‐Etayo, Daniel Arroyo‐Sánchez, et al. · HLA · 3
Two new HLA‐DQB1*03:02:01 variants with substitutions in intron 2: HLA‐DQB1*03:02:01:19 and ‐DQB1*03:02:01:21
2024 · Francisco Javier Gil‐Etayo, Daniel Arroyo‐Sánchez, et al. · HLA · 3
Detection of two HLA‐B*35 variants: HLA‐B*35:01:01:39 and ‐B*35:03:01:32
2024 · Daniel Arroyo‐Sánchez, Francisco Javier Gil‐Etayo, et al. · HLA · 3
PDF
Works count: 45
Citation count: 758
H-index: 10
I10-index: 10
Year
Topic
Type